Skip to main content
VCbacked
Log inGet Started

Jung+ Longevity

New York, United States

Jung+ focuses on biotech solutions for slowing aging and extending healthy lifespan through its Total Longevity SystemN.

$573K raised
Jan 2023
Pre-Seed
BiotechnologyConsumer GoodsHealth CareWellness

Top Investors

Fady Hannah-ShmouniMD FRCPCSebastian BrunemeierKhalili BrothersAbdullah ZaidGhalib Alireza

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Jung+ Longevity

How much funding has Jung+ Longevity raised?
Jung+ Longevity has raised $573K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2023.
Who are Jung+ Longevity's investors?
Jung+ Longevity's investors include Fady Hannah-Shmouni, MD FRCPC, Sebastian Brunemeier, Khalili Brothers, Abdullah Zaid, Ghalib Alireza.
Where is Jung+ Longevity headquartered?
Jung+ Longevity is headquartered in New York, United States.
What does Jung+ Longevity do?
Jung+ focuses on biotech solutions for slowing aging and extending healthy lifespan through its Total Longevity SystemN.
What stage is Jung+ Longevity at?
Jung+ Longevity is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Jung+ Longevity — Funding & Investors." VCBacked, January 1, 2023, https://www.vcbacked.co/company/jung-longevity. Accessed June 17, 2026.
APA
VCBacked. (2023). Jung+ Longevity — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/jung-longevity
Wikipedia (cite web)
{{cite web |title=Jung+ Longevity — Funding & Investors |url=https://www.vcbacked.co/company/jung-longevity |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong